ILCA: Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

Activity: Talk or presentation types › Lecture and oral contribution

Jesper Bøje Andersen - Speaker

    International Liver Cancer Association
    Hong Kong, PR China
    2011

    External organisation

    NameUnknown external organisation

    ID: 96522617